AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017 Why Theranos Could Burn Through All Its Cash by the End of This Year July 4, 2017 Tetraphase's Lead Antibiotic Fails Another Late-Stage Study February 13, 2018
SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017
